Biotechnology Companies in the News – March 2012

Editor’s Note: The home page of the BioNJ website provides an up-to-the-minute headline service where readers can access press releases issued by New Jersey-based biotechnology companies. Go to the “New Jersey Biotechnology Company News” section on the BioNJ home page to read the latest news. Companies wishing to appear in the Biolines Biotechnology Companies in the News section are encouraged to email their news releases to BioNJ.

March 20
ProCure, CentraState Healthcare System and Princeton Radiation Oncology Celebrate Grand Opening of New Jersey and Metro New York’s First Proton Therapy Center

March 19
CorMedix Reports Year End 2011 Financial Results

Advaxis Named to Shortlist for Vaccine Industry Excellence Award

March 16
SK Biopharmaceuticals to Initiate Phase 2 Trials in US

Novartis Acquires Rights to ThromboGenics Eye Drug

March 15
Merck Partners with Academic Scientists and Biotechnology Entrepreneurs to Create the California Institute for Biomedical Research (Calibr)

Cevira® Clinical Results Presented at ASCCP – Initial Results with Fully Integrated Drug-Device Combination

March 14
Celldex Announces Exercise of Over-Allotment Option

Unigene Appoints David Moskowitz as Chief Financial Officer

March 13
The Avoca Group Announces Inaugural Summit to Establish Best Practice Approach to Quality Management and CRO Oversight

March 8
Steve Carchedi to Join PCAsso Diagnostics’ Strategic Advisory Board

Unigene Announces Fourth Quarter and Full-Year 2011 Results

Celgene Completes Acquisition of Avila Therapeutics

Horizon NJ Health Rates as New Jersey’s Top Medicaid Managed Care Plan

March 7
Celldex Reports Fourth Quarter and Fiscal 2011 Financial Results

Immunomedics Appoints Marcella Locastro to Board of Directors

Pacira Pharmaceuticals, Inc. to Present at Barclays Capital Global Healthcare Conference

Senesco Adds Additional Clinical Site to Evaluate SNS01-T in Multiple Myeloma

SK Bio-Pharmaceuticals Announces New CEO, Dr. Christopher Gallen

MRI Contrast Agents Go Head-to-Head: Researchers Find Greater Morphologic Information and Lesion Enhancement with Bracco’s MultiHance®(gadobenate dimeglumine) Injection, 529 mg/mL When Compared to Gadavist™ (gadobutrol injection)

NPS Pharmaceuticals to Present at Barclays Capital Global Healthcare Conference

March 6
Aegerion Pharmaceuticals Announces Fourth-Quarter and Full-Year 2011 Financial Results

Paragon to Feature Change Management Solutions for Life Sciences at Model N Rainmaker Conference

Columbia Laboratories Receives Nasdaq Minimum Bid Price Non-compliance Letter

March 5
Merck to Present at the Cowen & Company 32nd Annual Health Care Conference

Merck’s Investigational Allergy Immunotherapy Tablet (AIT) Significantly Reduced the Combination of Ragweed Allergy Symptoms and Medication Use in Phase III Trial

Unigene’s Proprietary Peptelligence™ Platform Selected by Stealth Peptides for an Oral Phase 1 Clinical Study

Photocure Announces the Achievement of the Second Transition Milestone of Eur 1.5 Million for Hexvix®

Aegerion Pharmaceuticals Submits Marketing Applications for Lomitapide in U.S. and EU

Savient Announces Named Patient Programme for KRYSTEXXA® in the European Union for Patients with Refractory Chronic Gout

Dendreon Announces Webcast Presentation at Upcoming Conferences

March 2
Senesco Announces Additional $1.0 Million Equity Financing

Registration Open for One-Day Conference on Trusted Digital Identities and Cloud Collaboration in Biopharmaceutical Industry

March 1
Columbia Laboratories to Discuss Fourth Quarter and Year-End 2011 Financial Results on March 8, 2012, Conference Call

APR Applied Pharma Research (“APR”) and Labtec GmbH ( “Labtec”) Announce the European Approval of Zolmitriptan Oral Dispersible Film (ODF)

Bio-Reference Laboratories, Inc. Announces Record First Quarter Revenue, Earnings and Cash Flow from Operations

Senesco Adds Second Clinical Site to Evaluate SNS01-T in Multiple Myeloma

Unigene to Announce Fourth Quarter and Full-Year 2011 Financial Results on March 8, 2012

Columbia Laboratories Announces 42% Workforce Reduction

Company Profile for Biomatters Ltd

Amicus Therapeutics Announces Proposed Public Offering of Common Stock

Amicus Therapeutics Prices Underwritten Offering of Common Stock

February 29
NPS Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors

Columbia Laboratories Will Present March 5th at Cowen and Company Health Care Conference

Antares Pharma to Present at Upcoming Investor Conferences

Catalent Continues to Expand Global Softgel Drug Delivery Capabilities by Acquiring 100% of R.P. Scherer, Eberbach, Germany

U.S. Food and Drug Administration Extends Action Date for ELIQUIS® (apixaban) by Three Months

Public Health Experts Address Bristol-Myers Squibb Foundation Together on Diabetes® Grantees and Applaud Collaborations between Clinicians and Communities to Reduce Diabetes Disparities

Celldex Therapeutics to Host Corporate 2011 Year-End and 2012 Objectives Update Call

Aegerion Pharmaceuticals Observes Rare Disease Day 2012

Lexicon Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference

Gilead Sciences to Present at the Cowen & Company 32nd Annual Health Care Conference on Wednesday, March 7

Celldex Therapeutics to Host Corporate 2011 Year-End and 2012 Objectives Update Call

February 28
Bristol-Myers Squibb and Duke Translational Medicine Institute Form Strategic Relationship to Broaden Interactions

TYRX Announces Launch of New Patient Education Web Site HeartDeviceInfection.com

Alliance Life Sciences Sponsors Model N Rainmaker 2012 Conference, Releases White Paper on Proposed AMP Best Price Rule

Bristol-Myers Squibb to Present at Cowen and Company Health Care Conference

Amicus Therapeutics to Present at 2012 RBC Global Healthcare Conference

Johnson & Johnson to Participate in Cowen and Company 32nd Annual Health Care Conference

Dendreon Announces Executive Appointments

February 27
NPS Pharmaceuticals Observes Rare Disease Day 2012

Celgene Corporation to Present at Two Upcoming Investor Conferences

Advaxis Low Dose Cohort 1 Meets 50% Efficacy Target In CIN 2/3

Unigene to Present at Ibc’s 4th Annual Asiatides Oligonucleotide and Peptide® Conference

Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2011 Results

February 24
SorinRoyerCooper Named 2012 Life Sciences Law Firm of the Year

Sophion Invites the World to Q2 – a New Dimension in Automated Patch Clamping

Celldex Prices Public Offering of Common Stock

Data on Impact of Hexvix® on Long Term Recurrence Rates to be Presented at European Association of Urology (Eau) Congress, Paris

Gilead Sciences to Present at Two Upcoming Investor Conferences

Celldex Therapeutics to Present at the Citi 2012 Global Health Care Conference

February 23
Celldex Announces Public Offering of Common Stock

Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference

Savient Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference

February 22
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2011 Fourth Quarter and Full Year Financial Results

The Medicines Company Reports Full Year and Fourth Quarter 2011 Financial Results

February 21
Celgene Corporation to Present at the Citi 2012 Global Health Care Conference

Arno Therapeutics Receives Two Orphan-Drug Designations for AR-42 in Treatment of Central-Nervous-System Tumors

Soligenix Announces Positive Survival Results of SGX202 in Radiation Injury

J&J Announces Retirement of CEO

NPS Pharmaceuticals to Present at Upcoming Conferences

SK Biopharmaceuticals to Initiate Phase 2 Trials in US

The Medicines Company to Participate in Two Investor Conferences: 2012 Citi Global Healthcare Conference and 2012 RBC Capital Markets’ Global Healthcare Conference

February 18
Bristol-Myers Squibb Foundation Announces Grants Focused on Prevention, Diagnosis and Care of Hepatitis B and Hepatitis C in Asia

February 17
Experts Explain Role of Digital Identities in Transforming Healthcare to Fully Electronic Environment

Catalent Completes Acquisition of Clinical Trials Supplies Business of Aptuit LLC

February 16
Photocure ASA Results for the Fourth Quarter and Full Year 2011

February 15
Merck Establishes Joint Venture with Supera Farma to Commercialize Innovative Pharmaceutical Products and Branded Generics in Brazil

Senesco Technologies Reports Second Quarter Fiscal 2012 Financial Results

Derma Sciences to Present at the LHA Life Sciences & Medtech Virtual Conference on February 16

NPS Pharmaceuticals Reports 2011 Year-End Financial Results and 2012 Cash Burn Guidance

February 14
Arno Therapeutics Announces Exclusive Licensing Agreement with Invivis Pharmaceuticals to Develop Cancer Drug